in the drug pipeline they are truly worth looking at. I usually don’t like to buy options in stocks that have a huge market cap. At 185 Billion its next to impossible to get a double out it in stock. They options volume in the FEB 25 calls is almost Google-like. I think you can get a double out of the June 25 calls. Pfizer is trading at a discount to its peers because of that market cap and is quite a bargain in my eyes. It will break through its 200 day today of $25.38. I am a buyer of PFE today.

By